Skip Navigation


Hum. Reprod. Advance Access originally published online on January 23, 2006
Human Reproduction 2006 21(5):1237-1242; doi:10.1093/humrep/dei462
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow All Versions of this Article:
21/5/1237    most recent
dei462v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (11)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Melin, A.
Right arrow Articles by Bergqvist, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Melin, A.
Right arrow Articles by Bergqvist, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2006. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Endometriosis and the risk of cancer with special emphasis on ovarian cancer

A. Melin1,5, P. Sparén2, I. Persson2 and A. Bergqvist3,4

1 Department of Obstetrics & Gynaecology, Karolinska University Hospital Huddinge, 2 Department of Medical Epidemiology and Biostatistics, Karolinska Institute and 3 Department of Obstetrics & Gynaecology, Karolinska Institutet, Danderyds Hospital, Stockholm, Sweden

4 Present address: Pfizer AB, Täby, Sweden

5 To whom correspondence should be addressed at: Department of Obstetrics and Gynaecology, K57 Karolinska University Hospital, Huddinge, S-14186 Stockholm, Sweden. E-mail: anna-sofia.melin{at}karolinska.se

BACKGROUND: Several observations of the coexistence of endometriosis and cancer have been published. One study concerning endometriosis patients from 1969 to 1986 showed an overall relative cancer risk of 1.2 and relative risks for breast cancer, ovarian cancer and non-Hodgkin’s lymphoma to be 1.3, 1.9 and 1.8, respectively. The aim of this study was to see whether these risk ratios stand in an extended study with longer follow-up. METHODS: Women discharged from a hospital, with a diagnosis of endometriosis from 1969 to 2000, were identified using the National Swedish Inpatient Register. Data were linked to the National Swedish Cancer Register to identify cases of cancer. Data on hysterectomies and oophorectomies were available. Standardized incidence ratios (SIR) were calculated. RESULTS: 64 492 women entered the study. First year of follow-up was excluded, leaving 3349 cases of cancer. There was no increased overall risk of cancer [SIR 1.04, 95% CI 1.00–1.07]. Elevated risks were found for ovarian cancer (SIR 1.43, 95% CI 1.19–1.71), endocrine tumours (SIR 1.36, 95% CI 1.15–1.61), non-Hodgkin’s lymphoma (SIR 1.24, 95% CI 1.02–1.49) and brain tumours (SIR 1.22, 95% CI 1.04–1.41). Women with early diagnosed and long-standing endometriosis had a higher risk of ovarian cancer, with SIR of 2.01 and 2.23, respectively. The average age at endometriosis diagnosis was 39.4, indicating that there are the moderate/severe cases that are included in this study. Women who had a hysterectomy before or at the time of the endometriosis diagnosis did not show an increased risk of ovarian cancer. CONCLUSION: Women with endometriosis have an increased risk of some malignancies, particularly ovarian cancer, and the risk increases with early diagnosed or long-standing disease. Hysterectomy may have a preventive effect against ovarian cancer.

Key words: cancer/endometriosis/standardized incidence ratio/Sweden


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
M. L. Hull, C. R. Escareno, J. M. Godsland, J. R. Doig, C. M. Johnson, S. C. Phillips, S. K. Smith, S. Tavare, C. G. Print, and D. S. Charnock-Jones
Endometrial-Peritoneal Interactions during Endometriotic Lesion Establishment
Am. J. Pathol., September 1, 2008; 173(3): 700 - 715.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
Z. Z. Zhao, P. M. Pollock, S. Thomas, S. A. Treloar, D. R. Nyholt, and G. W. Montgomery
Common variation in the fibroblast growth factor receptor 2 gene is not associated with endometriosis risk
Hum. Reprod., July 1, 2008; 23(7): 1661 - 1668.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Melin, P. Sparen, and A. Bergqvist
The risk of cancer and the role of parity among women with endometriosis
Hum. Reprod., November 1, 2007; 22(11): 3021 - 3026.
[Abstract] [Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.